Except for one subject with positive [18F]flotaza for Aβ plaques and one with positive [125I]IPPI for tau, both with suspected AD, all other CN female subjects were found to be negative for Aβ plaques and tau. This evidence concerns the gene MAPT and Alzheimer disease.